Background: Inflammation, local joint destruction and systemic bone loss are common complications in patients with rheumatoid arthritis (RA). We have identified that localised pre-receptor activation of glucocorticoids (GC) by the enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11b-HSD1) is increased within sites of inflammation and surrounding tissues, such as synovium and bone. Whilst this greatly increases local bioavailability of cortisol, which supports resolution of inflammation, in chronic disease, GCs drive may drive catabolic pathways that contribute to joint destruction and systemic bone loss. Methods: To determine the contribution of 11b-HSD1 activated glucocorticoids to joint destruction and inflammatory bone loss, we crossed an 11b-HSD1 null mouse onto a transgenic murine model of chronic polyarthritis (TNF-Tg) to generate TNF-tg 11bKO mice. Clinical measures of joint inflammation, mobility and behaviour were collected between four and nine weeks of age. Paw swelling was determined using calliper measurements. Histology was assessed in formalin fixed sections following staining with haematoxylin and eosin, safranin O or TRAP staining. Juxta articular and systemic bone losses were measured by micro-Ct. synovitis was determined by Image J analysis of histology sections. Results: 11b-HSD1 was completely knocked out within sites of inflammation in the TNF-tg 11bKO mouse. At nine weeks, both clinical and inflammation scores were markedly exacerbated in TNF-tg 11bKO animals relative to TNF-tg counterparts (inflammation score; TNF-tg, 4.3 AE 2.26 versus TNF-tg 11bKO , 11.08 AE 0.86; p < 0.001). This was supported by marked increases in joint swelling and juxta articular bone loss from these animals (erosion scores, TNFtg, 5.2 AE 0.61 versus TNF-tg 11bKO , 9.0 AE 0.66; p < 0.005). Closer examination of joint destruction revealed that the pannus was larger and more extensive within subchondral bone, whilst evidence of cartilage degradation was significantly worse in the TNF-tg 11bKO mouse (synovitis size, TNFtg, 26763 (AU) AE 3200 versus TNF-tg 11bKO , 530276 AE 3225; p < 0.005). Systemic bone loss determined by bone volume to tissue volume (BV/ TV), trabecular thickness (TT) and trabecular number (TN) was also greatly exacerbated within the TNF-tg 11bKO mouse (TNF-tg, BV/TV 5.7 AE 0.75, TT 73.5 AE 6.4, TN 0.00077 AE 0.00004 versus TNF-tg 11bKO BV/ TV 1.8 AE 0.36, TT 7359.77 AE 3.7, TN 0.0003 AE 0.00005; P < 0.001, P < 0.005, P < 0.001 respectively). Conclusion: This study demonstrates that rather than contributing to catabolic pathways of tissue destruction, local GC activation by 11b-HSD1 is critical in mediating the suppression inflammation, joint destruction, synovitis and inflammatory bone loss in this murine model of chronic polyarthritis. Disclosures: The authors have declared no conflicts of interest. Background: Spondyloarthritis (SpA) describes a group of inflammatory joint diseases affecting $1% of the population. SpA has strong genetic associations with HLA-B/RUNX3 implying a role for CD8þ T-cells. Furthermore, genetic associations with IL23R/TRAF3IP2 and the clinical efficacy of IL-17 blockade in SpA, indicate a role for IL-17 in these diseases. This led us to investigate the presence, phenotype and functional capacity of IL-17þCD8þ T-cells in the joints of patients with SpA. Methods: Mononuclear cells were isolated from peripheral blood (PB) and synovial fluid (SF) from patients with PsA, other peripheral-SpA types (including ankylosing spondylitis/non-radiographic axial SpA/ reactive arthritis/enteropathic arthritis/undifferentiated SpA) and rheumatoid arthritis (RA). Cells were stimulated ex-vivo before analysis of surface marker/cytokine expression by flow cytometry or cytokine secretion assay. Sorting was performed on unstimulated SFMC and gene expression analysis performed by RT-PCR. Results: Frequencies of IL-17þCD8þ T-cells were increased in the SF of PsA (p ¼ 0.0005) and SpA (p ¼ 0.0009), but not RA patients (p ¼ 0.3) vs. paired PB, with IL-17 secretion confirmed by cytokine secretion assay. This increase was not dependent on carriage of HLA-B27 haplotype. Phenotypically, SF IL-17þCD8þ T-cells were largely composed of TCRabþ T-cells ($95%), with small proportions of MAIT/
Background: Inflammation, local joint destruction and systemic bone loss are common complications in patients with rheumatoid arthritis (RA). We have identified that localised pre-receptor activation of glucocorticoids (GC) by the enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11b-HSD1) is increased within sites of inflammation and surrounding tissues, such as synovium and bone. Whilst this greatly increases local bioavailability of cortisol, which supports resolution of inflammation, in chronic disease, GCs drive may drive catabolic pathways that contribute to joint destruction and systemic bone loss. Methods: To determine the contribution of 11b-HSD1 activated glucocorticoids to joint destruction and inflammatory bone loss, we crossed an 11b-HSD1 null mouse onto a transgenic murine model of chronic polyarthritis (TNF-Tg) to generate TNF-tg 11bKO mice. Clinical measures of joint inflammation, mobility and behaviour were collected between four and nine weeks of age. Paw swelling was determined using calliper measurements. Histology was assessed in formalin fixed sections following staining with haematoxylin and eosin, safranin O or TRAP staining. Juxta articular and systemic bone losses were measured by micro-Ct. synovitis was determined by Image J analysis of histology sections. Results: 11b-HSD1 was completely knocked out within sites of inflammation in the TNF-tg 11bKO mouse. At nine weeks, both clinical and inflammation scores were markedly exacerbated in TNF-tg 11bKO animals relative to TNF-tg counterparts (inflammation score; TNF-tg, 4.3 AE 2.26 versus TNF-tg 11bKO , 11.08 AE 0.86; p < 0.001). This was supported by marked increases in joint swelling and juxta articular bone loss from these animals (erosion scores, TNFtg, 5.2 AE 0.61 versus TNF-tg 11bKO , 9.0 AE 0.66; p < 0.005). Closer examination of joint destruction revealed that the pannus was larger and more extensive within subchondral bone, whilst evidence of cartilage degradation was significantly worse in the TNF-tg 11bKO mouse (synovitis size, TNFtg, 26763 (AU) AE 3200 versus TNF-tg 11bKO , 530276 AE 3225; p < 0.005). Systemic bone loss determined by bone volume to tissue volume (BV/ TV), trabecular thickness (TT) and trabecular number (TN) was also greatly exacerbated within the TNF-tg 11bKO mouse (TNF-tg, BV/TV 5.7 AE 0.75, TT 73.5 AE 6.4, TN 0.00077 AE 0.00004 versus TNF-tg 11bKO BV/ TV 1.8 AE 0.36, TT 7359.77 AE 3.7, TN 0.0003 AE 0.00005; P < 0.001, P < 0.005, P < 0.001 respectively). Conclusion: This study demonstrates that rather than contributing to catabolic pathways of tissue destruction, local GC activation by 11b-HSD1 is critical in mediating the suppression inflammation, joint destruction, synovitis and inflammatory bone loss in this murine model of chronic polyarthritis. Disclosures: The authors have declared no conflicts of interest. Background: Spondyloarthritis (SpA) describes a group of inflammatory joint diseases affecting $1% of the population. SpA has strong genetic associations with HLA-B/RUNX3 implying a role for CD8þ T-cells. Furthermore, genetic associations with IL23R/TRAF3IP2 and the clinical efficacy of IL-17 blockade in SpA, indicate a role for IL-17 in these diseases. This led us to investigate the presence, phenotype and functional capacity of IL-17þCD8þ T-cells in the joints of patients with SpA. Methods: Mononuclear cells were isolated from peripheral blood (PB) and synovial fluid (SF) from patients with PsA, other peripheral-SpA types (including ankylosing spondylitis/non-radiographic axial SpA/ reactive arthritis/enteropathic arthritis/undifferentiated SpA) and rheumatoid arthritis (RA). Cells were stimulated ex-vivo before analysis of surface marker/cytokine expression by flow cytometry or cytokine secretion assay. Sorting was performed on unstimulated SFMC and gene expression analysis performed by RT-PCR. Results: Frequencies of IL-17þCD8þ T-cells were increased in the SF of PsA (p ¼ 0.0005) and SpA (p ¼ 0.0009), but not RA patients (p ¼ 0.3) vs. paired PB, with IL-17 secretion confirmed by cytokine secretion assay. This increase was not dependent on carriage of HLA-B27 haplotype. Phenotypically, SF IL-17þCD8þ T-cells were largely composed of TCRabþ T-cells ($95%), with small proportions of MAIT/ NK/g-T-cells (all <5%). Synovial fluid IL-17þCD8þ T-cells displayed general characteristics of IL-17þ cells (CCR6/CD161 expression) but also of tissue resident memory T cells (T RM ; CD45RA-CCR7-CD103þ). Indeed, when we sorted CD8þCD69þCD103þ T RM cells from the PsA joint, they were enriched for IL-17, whilst expressing RORC transcript. Functionally, a high frequency of SF IL-17þCD8þ T-cells coexpressed pro-inflammatory cytokines IFN-g, GM-CSF, TNF-a, some IL-21 and IL-22, but very little anti-inflammatory IL-10. Considerable proportions of SF IL-17þCD8þ T-cells expressed skin-related markers CD49a (median-57%) and cutaneous lymphocyte antigen (27%), suggesting homing potential between these tissue sites. Conclusion: These novel findings show an enrichment of IL-17þCD8þ T cells in the joints of patients across multiple SpA types, with some cells exhibiting markers of skin homing. Synovial IL-17þCD8þ T-cells have hallmarks of tissue-resident memory cells, the first description of these cells in the synovial fluid. Functionally IL-17þ CD8þ T cells exhibit a high pro-inflammatory potential, indicating that these cells may be important contributors to the pathogenesis of SpA. Background: Macrophages are well known to play a critical role in RA pathogenesis. There is conflicting evidence as to the phenotype of macrophages in RA synovium, but multiple studies suggest a proinflammatory macrophage phenotype predominates. Translocator protein (TSPO) is an 18kDa mitochondrial transporter, increasingly thought to play a critical role in cholesterol efflux in macrophages. Recent data indicates that macrophages engineered to over-express TSPO exhibit increased cholesterol efflux and reduced ability to form a pro-inflammatory (M1) phenotype in response to activation by proinflammatory stimuli, such as lipopolysaccharide (LPS). In this study, we investigate the expression of TSPO in peripheral blood monocytes, and monocyte-derived macrophages (MDM) isolated from healthy volunteers and patients with RA. Methods: Using magnetic activated cell sorting, monocytes were extracted from peripheral blood mononuclear cells of 24 patients with RA (10 male, 14 female, age range 32-66, with active disease as determined by DAS28 CRP score) and 24 healthy controls (11 male, 13 female, age range 30-65). Monocytes were differentiated in vitro to produce MDM which were either activated to pro-inflammatory M1 (using LPS and IFN-8) or reparative M2 (using IL-4, TGF-b or glucocorticoid) phenotypes. TSPO mRNA and protein levels in monocytes, M1 & M2 phenotypes were measured and compared. Results: Our data established that MDM from both healthy and RA monocytes, when activated to a pro-inflammatory M1 phenotype, exhibited a statistically significant downregulation of TSPO at mRNA and protein level. However, no changes were noted in TSPO expression in MDM activated to a reparative M2 phenotype. Our mRNA data also suggests that M1 macrophages from both healthy and RA donors exhibited a significant reduction in expression of key cell components promoting cholesterol efflux in macrophages, including CYP27A1, and ABCA1. TSPO expression was significantly lower in RA monocytes compared to healthy at both mRNA and protein level (mean fold change TSPO mRNA of 1.00 for healthy monocytes, and 0.47 AE 0.24, p < 0.001 for RA monocytes and mean TSPO optical densitometry of 1.01 AE 0.10 for healthy monocytes and 0.80 AE 0.02 p < 0.05 for RA monocytes relative to b-actin). Conclusion: Our findings indicate that pro-inflammatory activation of both healthy and RA monocyte-derived macrophages downregulates TSPO, and is also associated with a reduction in key components of the cholesterol efflux pathway; in keeping with pre-existing reports of the effects of either TSPO silencing or over-expression in human macrophages. Furthermore, we demonstrate a relative downregulation of TSPO expression in RA as compared with healthy peripheral blood monocytes themselves, suggesting that TSPO downregulation in RA monocytes may be a novel pathogenic mechanism in RA which may predispose to a pro-inflammatory macrophage phenotype, and the potentiation of inflammation.
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